Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Kit and method for detecting mutations in CTNNB1 and hTERT, and use thereof in HCC detection and disease management

Kit and method for detecting mutations in CTNNB1 and hTERT, and use thereof in HCC detection and disease management

US Patent 10689709 · Granted Jun 23, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant Escherichia coli for producing glutarate, construction method and us2025
Drug combination containing TLR7 agonist2025
Acid phosphatase mutants and methods of using the same2025
TLR7 agonist for treating colorectal cancer and pharmaceutical combination there2025
TLR7 agonist and pharmaceutical combination thereof for treating lung cancer2024
Pharmaceutical compositions comprising iodine and steroid and uses thereof for s2024
Recombinant Escherichia coli strain for producing succinic acid and construction2024
Preparation of L-amino acid deaminase mutant and application thereof2023
Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparin2022
Polyanion active materials and method of forming the same2021
Removal of bromine index-reactive compounds2021
Method of making injectable cements2020